en

PRODUCT DETAIL

Apremilast STADA 10 mg filmom obalené tablety Apremilast STADA 20 mg filmom obalené tablety Apremilast STADA 30 mg filmom obalené tablety

Code 9036E
MA number 59/0059/25-S
Product Form: tbl flm 27 (4 x 10 mg + 4 x 20 mg + 19 x 30 mg) (blis.PVC/Al - bal.na zač.liečby)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: STADA Arzneimittel AG, Germany
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA32 Apremilast
Shelf life: 60
Container: blister PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 24.02.2025
Validity: 24.02.2030
PIL: PIL_Apremilast STADA_02.2025.pdf  
SPC: SPC_Apremilast STADA_02.2025.pdf  
Safety feature Yes
Data update: 26.02.2025
eu-flag.png sk-flag.png